Acceso a usuarios
Bienvenid@

Tutores

GUILLERMO DE ANDA JÁUREGUI

Instituto Nacional de Medicina Genómica (INMEGEN)

Contacto

Teléfono: 55 5510077729
Email: gdeanda@inmegen.edu.mx
Sitio web: Visitar sitio web

Campos de conocimiento

Bioinformática
Ciencias Genómicas
Farmacología

Líneas de investigación

Ciencia de datos biomédicos
Ciencia de redes biomédicas
Farmacología de Sistemas
Sistemas Complejos y Salud

Publicaciones

End-point RT-PCR based on a conservation landscape for SARS-COV-2 detection
Scientific reports 12 (1), 1-13 2022
IF 5.134

Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City
Viruses 14 (3), 545 2022
IF 5.048

Territorial Strategy of Medical Units for Addressing the First Wave of the COVID-19 Pandemic in the Metropolitan Area of Mexico City: Analysis of Mobility, Accessibility and …
International Journal of Environmental Research and Public Health 19 (2), 665 1 2022
IF 3.390

Automated Reverse Transcription Polymerase Chain Reaction Data Analysis for Sars-CoV-2 Detection
Revista de investigación clínica 73 (6), 339-346 1 2021
IF 1.451

The evolutionary landscape of SARS-CoV-2 variant B. 1.1. 519 and its clinical impact in Mexico City
Viruses 13 (11), 2182 6 2021
IF 5.048

In silico identification of excretory/secretory proteins and drug targets in monogenean parasites
Infection, Genetics and Evolution 93, 104931 2021
IF 3.342

Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes
Interface focus 11 (4), 20200073 2 2021
IF 3.906

A meta-study on transcription factor networks in the suicidal brain
Journal of psychiatric research 136, 23-31 1 2021
IF 4.791

An information theoretical multilayer network approach to breast cancer transcriptional regulation
Frontiers in genetics 12, 232 2 2021
IF 4.599

Gene-Microbiome Co-expression Networks in Colon Cancer
Frontiers in genetics 12, 152 1 2021
IF 4.599

Diffusion processes in multilayer transportation networks: the flight of the Coronavirus
Revista Mexicana Física 66 (4), 516 4 2020
IF 1.297

Multi-omic regulation of the pam50 gene signature in breast cancer molecular subtypes
Frontiers in oncology 10, 845 5 2020
IF 6.244

Computational oncology in the multi-omics era: state of the art
Frontiers in Oncology 10, 423 43 2020
IF 6.244

Gene co-expression is distance-dependent in breast cancer
Frontiers in oncology, 1232 9 2020
IF 6.244

Functional and transcriptional connectivity of communities in breast cancer co-expression networks
Applied Network Science 4 (1), 1-13 14 2019
Citescore 2.3

Guideline for comparing functional enrichment of biological network modular structures
Applied Network Science 4 (1), 1-17 3 2019
Citescore 2.3

Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone
BMC systems biology 13 (1), 1-11 11 2019
IF 2.048

A Boolean Network Approach to Estrogen Transcriptional Regulation
Complexity 2019 2 2019
IF 2.833

A Network Pharmacology Approach for the Identification of Common Mechanisms of Drug‐Induced Peripheral Neuropathy
CPT: pharmacometrics & systems pharmacology 8 (4), 211-219 4 2019
IF 4.054

Spatial organization of the gene regulatory program: an information theoretical approach to breast cancer transcriptomics
Entropy 21 (2), 195 10 2019
IF 2.524

Identification of Casiopeina II-gly secondary targets through a systems pharmacology approach
Computational Biology and Chemistry 78, 127-132 8 2019
IF 2.877

Intrachromosomal regulation decay in breast cancer
Applied Mathematics and Nonlinear Sciences 4 (1), 223-230 11 2019
IF NA

Network-based assessment of adverse drug reaction risk in polypharmacy using high-throughput screening data
International journal of molecular sciences 20 (2), 386 6 2019
IF 5.924

Conserved transcriptional signatures in human and murine diabetic peripheral neuropathy
Scientific reports 8 (1), 1-11 29 2018
IF 5.134

Nonredundant, highly connected microRNAs control functionality in breast cancer networks
International journal of genomics 2018 17 2018
IF 2.326



Exploration of the anti-inflammatory drug space through network pharmacology: applications for drug repurposing
Frontiers in physiology 9, 151 12 2018
IF 4.566

The hierarchical modular structure of HER2+ breast cancer network
Frontiers in physiology, 1423 18 2018
IF 4.566

Network modularity in breast cancer molecular subtypes
Frontiers in physiology 8, 915 25 2017
IF 4.566

RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer
Scientific reports 7 (1), 1-19 31 2017
IF 5.134
Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx
UNAM Posgrado